Newsroom

Sorted by: Latest
-

BellRing Brands Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of BellRing Brands, Inc. - BRBR

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into BellRing Brands, Inc. (NYSE: BRBR) (“BellRing” or the “Company”). On August 4, 2025, the Company reported its fiscal 3Q 2025 financial results, disclosing a disappointing new 2025 sales outlook, stating “BellRing management has narrowed its fiscal year 2025 outlook f...
-

MISTRAS Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of MISTRAS Group, Inc. - MG

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of MISTRAS Group, Inc. (NYSE: MG) to affiliates of H.I.G. Capital. Under the terms of the proposed transaction, shareholders of MISTRAS will receive $20.35 in cash for each share of MISTRAS that they own. KSF is seeking to determine whether this consideration and the process that led to it are ade...
-

PRCT Deadline: Rosen Law Firm Urges PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the “Class Period”). PROCEPT is a medical technology company.For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653.The Allegations: Rosen Law Firm is Investigating the Allegat...
-

K-Era Fest Brings the Korean Wave to the Pacific Northwest October 24-25

SEATTLE--(BUSINESS WIRE)--The Pacific Northwest's first, large-scale Korean Wave festival arrives Oct 24-25 featuring global talent, cultural leaders and industry icons....
-

MaaT Pharma Announces Upcoming Pre-IND Meeting with the FDA and Advances MaaT034 Toward Clinical Development in Solid Tumors

LYON, France--(BUSINESS WIRE)--MaaT Pharma Announces Upcoming Pre-IND Meeting with the FDA and Advances MaaT034 Toward Clinical Development in Solid Tumors...
-

MaaT Pharma annonce la tenue prochaine d’une réunion pré-IND avec la FDA et poursuit l’avancement de MaaT034 vers son développement clinique dans les tumeurs solides

LYON, France--(BUSINESS WIRE)--Regulatory News: MaaT Pharma (EURONEXT : MAAT - la « Société »), société de biotechnologies en stade clinique avancé, leader dans le développement de Microbiome Ecosystem TherapiesTM (MET) visant à améliorer la survie des patients atteints de cancer grâce à la modulation du système immunitaire, annonce aujourd’hui les prochaines étapes du développement clinique de MaaT034, premier écosystème microbien co-cultivé et sélectionné sur la base de ses fonctions, issu de...
-

ABL Texcell Diagnostics Reaches a New Strategic Milestone With a Proposed Acquisition of Vela Diagnostics' Activities in Singapore and the United States

WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics (Euronext Paris: ABLD – ISIN: FR001400AHX6) (the "Company"), a company specializing in molecular diagnostic solutions, healthcare software and clinical research services, announces that it has signed, alongside Advanced Biological Laboratories S.A. (ABL), its parent company, a non-binding letter of intent for a proposed acquisition of 100% of the share capital of Vela Operations Singapore Pte. Ltd. and Vela Diagnostics USA Inc. T...
-

ABL Texcell Diagnostics franchit une nouvelle étape stratégique avec un projet d’acquisition des activités de Vela Diagnostics à Singapour et aux États-Unis

WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics (Euronext Paris : ABLD – ISIN : FR001400AHX6) (la « Société »), société spécialisée dans les solutions de diagnostic moléculaire, les logiciels de santé et les services associés à la recherche clinique, annonce avoir signé, aux côtés d’Advanced Biological Laboratories S.A. (ABL), sa société-mère, une lettre d’intention non contraignante portant sur un projet d’acquisition de 100 % du capital de Vela Operations Singapore Pte. Ltd....
-

RXT Deadline: Rosen Law Firm Urges Rackspace Technology, Inc. (NASDAQ: RXT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of securities of Rackspace Technology, Inc. (NASDAQ: RXT) between May 6, 2026 and July 8, 2026, inclusive (the “Class Period”). Rackspace is a hybrid cloud and AI solutions company.For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653.The Allegations: Rosen Law Firm is Investigating the Allegations t...
-

Riassunto: Lenovo e Schneider Electric si alleano per portare strumenti e competenze di decarbonizzazione a IT Channel Partners

MORRISVILLE, N.C.--(BUSINESS WIRE)--Lenovo oggi ha annunciato che Schneider Electric, un leader nella tecnologia energetica globale, si unirà a Lenovo 360 Circle come alleato strategico per fornire competenze e strumenti di gestione per la decarbonizzazione direttamente ai partner di canale informatici. Lenovo 360 Circle è la comunità globale di Lenovo per la sostenibilità che integra i partner di canale di tutto il mondo per collaborare alle sfide condivise, accelerare la trasformazione della...